Prometheus Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prometheus Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
  • Prometheus Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $9.38M, a 186% increase year-over-year.
  • Prometheus Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $27M, a 105% increase year-over-year.
  • Prometheus Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.9M, a 95% increase from 2021.
  • Prometheus Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.7M, a 1174% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $20.9M +$10.2M +95% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 $10.7M +$9.86M +1174% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $840K Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.